Skip to main content

Featured

Missile Barrage Deepens Middle East Crisis as Iran Mocks Trump’s Strait Proposal

                                   Emergency personnel respond at a site following Iranian missile barrages in central Israel Iran unleashed multiple waves of missiles on Israel, intensifying a conflict already engulfing the Middle East. The strikes came just a day after U.S. President Donald Trump claimed “very good and productive” talks were underway to halt the war. Israeli officials, however, doubted Iran would accept U.S. terms, and Tehran insisted no negotiations had taken place.  Tehran openly ridiculed Trump’s suggestion that the U.S. and Iran could jointly control the Strait of Hormuz, posting an image of a child’s pink toy steering wheel on social media. The symbolic jab underscored Iran’s rejection of Washington’s overtures and highlighted the growing influence of the Islamic Revolutionary Guard Corps, whose former commander Mohammad Baqer Zolqadr was appointed to l...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment